Free Trial

WORK Medical Technology Group LTD Ordinary Shares (WOK) Competitors

$6.06 -0.36 (-5.61%)
(As of 11/15/2024 ET)

WOK vs. ANGO, LUNG, DCTH, ANIK, UTMD, NYXH, OBIO, SGHT, SKIN, and NPCE

Should you be buying WORK Medical Technology Group LTD Ordinary Shares stock or one of its competitors? The main competitors of WORK Medical Technology Group LTD Ordinary Shares include AngioDynamics (ANGO), Pulmonx (LUNG), Delcath Systems (DCTH), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Nyxoah (NYXH), Orchestra BioMed (OBIO), Sight Sciences (SGHT), Beauty Health (SKIN), and NeuroPace (NPCE). These companies are all part of the "surgical & medical instruments" industry.

WORK Medical Technology Group LTD Ordinary Shares vs.

WORK Medical Technology Group LTD Ordinary Shares (NASDAQ:WOK) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.

AngioDynamics received 367 more outperform votes than WORK Medical Technology Group LTD Ordinary Shares when rated by MarketBeat users.

CompanyUnderperformOutperform
WORK Medical Technology Group LTD Ordinary SharesN/AN/A
AngioDynamicsOutperform Votes
367
61.06%
Underperform Votes
234
38.94%

89.4% of AngioDynamics shares are owned by institutional investors. 5.4% of AngioDynamics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

AngioDynamics has a consensus price target of $12.00, indicating a potential upside of 75.95%. Given AngioDynamics' stronger consensus rating and higher possible upside, analysts plainly believe AngioDynamics is more favorable than WORK Medical Technology Group LTD Ordinary Shares.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group LTD Ordinary Shares
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AngioDynamics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

WORK Medical Technology Group LTD Ordinary Shares has a net margin of 0.00% compared to AngioDynamics' net margin of -83.95%. WORK Medical Technology Group LTD Ordinary Shares' return on equity of 0.00% beat AngioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
WORK Medical Technology Group LTD Ordinary SharesN/A N/A N/A
AngioDynamics -83.95%-5.86%-4.17%

WORK Medical Technology Group LTD Ordinary Shares has higher earnings, but lower revenue than AngioDynamics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/A
AngioDynamics$303.91M0.91-$184.35M-$6.09-1.12

In the previous week, AngioDynamics had 4 more articles in the media than WORK Medical Technology Group LTD Ordinary Shares. MarketBeat recorded 5 mentions for AngioDynamics and 1 mentions for WORK Medical Technology Group LTD Ordinary Shares. WORK Medical Technology Group LTD Ordinary Shares' average media sentiment score of 1.91 beat AngioDynamics' score of 1.35 indicating that WORK Medical Technology Group LTD Ordinary Shares is being referred to more favorably in the media.

Company Overall Sentiment
WORK Medical Technology Group LTD Ordinary Shares Very Positive
AngioDynamics Positive

Summary

AngioDynamics beats WORK Medical Technology Group LTD Ordinary Shares on 8 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WOK vs. The Competition

MetricWORK Medical Technology Group LTD Ordinary SharesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$87.87M$4.59B$5.06B$8.69B
Dividend YieldN/A39.54%4.97%4.05%
P/E RatioN/A17.74109.7415.25
Price / SalesN/A57.821,275.8685.96
Price / CashN/A51.7739.7336.41
Price / BookN/A5.606.295.85
Net IncomeN/A$13.76M$118.73M$225.13M
7 Day Performance6.88%-3.63%-3.54%-2.12%
1 Month Performance9.58%2.96%-0.15%2.52%
1 Year PerformanceN/A50.86%32.01%23.54%

WORK Medical Technology Group LTD Ordinary Shares Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/A$6.06
-5.6%
N/AN/A$93.09M$9.86M0.00226Positive News
ANGO
AngioDynamics
4.7849 of 5 stars
$7.14
-4.0%
N/A-1.9%$290.13M$292.73M-1.17748Short Interest ↓
News Coverage
Positive News
LUNG
Pulmonx
3.4611 of 5 stars
$7.03
-6.9%
N/A-41.4%$277.62M$68.68M-4.78250Short Interest ↓
DCTH
Delcath Systems
3.6909 of 5 stars
$9.70
-2.6%
N/A+297.9%$269.56M$2.07M-7.1976Short Interest ↓
Analyst Revision
High Trading Volume
ANIK
Anika Therapeutics
3.8958 of 5 stars
$16.88
-1.1%
N/A-15.8%$247.22M$164.17M-2.54357High Trading Volume
UTMD
Utah Medical Products
3.5058 of 5 stars
$68.35
-0.2%
N/A-23.0%$237.86M$50.22M16.01180
NYXH
Nyxoah
2.9154 of 5 stars
$8.80
-3.6%
N/A+68.4%$219.47M$5.08M-4.71146Short Interest ↓
OBIO
Orchestra BioMed
2.5119 of 5 stars
$5.66
-7.7%
N/A-18.0%$214.09M$2.08M-3.5856Earnings Report
Analyst Forecast
News Coverage
SGHT
Sight Sciences
2.3669 of 5 stars
$4.23
-7.8%
N/A+83.6%$212.80M$79.40M-4.15210Analyst Revision
SKIN
Beauty Health
3.2192 of 5 stars
$1.70
-3.4%
N/A-19.5%$210.83M$366.23M-2.051,030Analyst Forecast
NPCE
NeuroPace
3.6819 of 5 stars
$7.14
-1.9%
N/A+3.2%$208.47M$71.82M-6.55170Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NASDAQ:WOK) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners